RecruitingNCT02026388

Rare Kidney Stone Consortium Biobank

Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network


Sponsor

Mayo Clinic

Enrollment

2,000 participants

Start Date

May 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with aprt deficiency, cystinuria, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02026388


Related Trials